Cardinal Health Inc (CAH)

Industry Medical Distribution

This stock can be held in an Investment ISA and an Investment Account

Sell

$214.00

Buy

$216.12

arrow-up$2.03 (+0.96%)

Prices updated at 03 Apr 2026, 00:48 EDT

Prices minimum 15 mins delay

Prices in USD

Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

S&P 500

0.11%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Distribution

Chairman

Ms. Patricia A. Hemingway Hall

CEO

Mr. Jason M. Hollar

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

57,700

Head office

7000 Cardinal Place

Dublin

United States

43017

+1 614 757-5000

Kevin.Moran@cardinalhealth.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Patricia A. Hemingway Hall Chairman of the Board	0.14m
Ms. Mary C. Scherer Senior Vice President and Chief Accounting Officer	-
Mr. David C. Evans Independent Director	0.12m
Mr. Robert W. Musslewhite Independent Director	0.04m
Ms. Sheri H. Edison Independent Director	0.14m
Mr. Sudhakar Ramakrishna Independent Director	0.04m
Mr. Akhil Johri Independent Director	0.15m
Ms. Nancy Killefer Independent Director	0.14m
Mr. Robert W. Azelby Independent Director	0.12m
Mr. Jason M. Hollar Chief Executive Officer and Director	1.49m
Mr. Aaron E. Alt Chief Financial Officer	0.87m
Ms. Ola M. Snow Chief Human Resources Officer	-
Ms. Christine A. Mundkur Independent Director	0.12m
Ms. Jessica L. Mayer Chief Legal and Compliance Officer	0.72m
Mr. Stephen M. Mason Chief Executive Officer, GMPD Segment	0.74m
Ms. Michelle M. Brennan Independent Director	0.12m
Ms. Michelle D. Greene Chief Information Officer and Executive Vice President, Customer Support Services	-
Ms. Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions segment	0.74m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	31,464,655
Vanguard Group Inc	31,441,258
State Street Corp	12,287,733
BlackRock Fund Advisors	9,908,735
Vanguard	9,412,048

Director dealings

Date chevron-l-regular chevron-r-regular	Action
01 Dec 2025	-
01 Dec 2025	-
01 Dec 2025	-
01 Dec 2025	-
01 Dec 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
05 Nov 2025	-
20 Aug 2025	-
20 Aug 2025	-
20 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.